TEST BANK
Rau's Respiratory Care Pharmacology 11th Edition by Douglas S. Gardenhire.
This complete test bank for Rau's Respiratory Care Pharmacology provides fully verified exam questions and answers
designed to help respiratory therapy students master key drug concepts, clinical applications, and pharmacologic
principles.
It includes chapter-specific questions, rationales, and updated practice sets covering respiratory drug classes,
therapeutic applications, mechanisms of action, side-effect profiles, and patient-care scenarios.
Perfect for RT students, nursing students, and health-science learners who want accurate, high-quality study material
that mirrors real course assessments.
Download instantly and start preparing with confidence.
Description
Test Bank for Rau’s Respiratory Care Pharmacology 11th Edition Gardenhire
, Table of Contents
ni andaUnit
akan I: menemui bahanand
Basic Concepts pembelajaran
Principles inyang disusun dengan teliti untuk membantu anda
Pharmacology
belajar dengan lebih mudah dan berkesan. Setiap dokumen direka secara teratur supaya maklumat
1. Introduction
penting senang to Respiratory
difahami Care
dan diingati. Pharmacology
Bahan ini sesuai untuk persediaan peperiksaan, ulang kaji,
2. Principles of Drug Action
dan pengukuhan pengetahuan. Kualiti dan ketepatan sentiasa menjadi keutamaan, memastikan
3. Administration
anda boleh belajar dengan of Aerosolized Agents
yakin. Pelajar menghargai ringkasan yang jelas dan penerangan
4. Calculating Drug Doses
praktikal yang menjimatkan masa serta mengurangkan tekanan. Matlamat saya adalah untuk
5. The
menjadikan Central and Peripheral
pengalaman Nervous
belajar anda lebih Systems
teratur dan produktif. Muat turun dengan keyakinan dan
gunakan sumber ini untuk meningkatkan prestasi akademik anda secara konsisten.
Unit II: Drugs Used to Treat the Respiratory System
Czech (±130 words)
6. Adrenergic (Sympathomimetic) Bronchodilators
Vítejte v7.mém
Anticholinergic
obchodě na (Parasympatholytic)
Stuvia! Najdete zdeBronchodilators
pečlivě připravené studijní materiály navržené tak,
8. Xanthines
aby bylo učení jednodušší a efektivnější. Každý dokument má přehlednou strukturu, která
usnadňuje9. Mucus-Controlling Drug informací.
pochopení důležitých Therapy Materiály jsou ideální pro přípravu na zkoušky,
10. Surfactant Agents
opakování i prohlubování znalostí. Důraz je kladen na kvalitu a spolehlivost, takže můžete studovat
11.Studenti
s jistotou. Corticosteriods
oceňujíinj Respiratory Care
12. Nonsteroidal Antiasthma Agents
13. Aerosolized Antiinfective Agents
14. Antimicrobial Agents
15. Cold and Cough Agents
16. Selected Agents of Pulmonary Value
17. Neonatal and Pediatric Aerosolized Drug Therapy
Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
19. Diuretic Agents
20. Drugs Affecting the Central Nervous System
21. Vasopressors, Inotropes, and Antiarrythmic Agents
22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
23. Sleep and Sleep Pharmacology
,Chapter 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th Edition
MULTIPLE CHOICE
1. Acetylcholine stimulates
a. the Vagus nerve.
b. the adrenergic receptors.
c. the sympathetic nervous system.
d. the cholinergic receptors.
ANS: D
Acetylcholine stimulates the cholinergic receptors.
PTS: 1
2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an increased
cardiac output?
a. Beta 1 receptor c. Alpha receptor
b. Beta 2 receptor d. Delta receptor
ANS: A
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias, and
an increased cardiac output. In administering drugs to the pulmonary system, stimulation of the beta-1
sites is not desired. However, most respiratory pharmacologic agents have some beta-1 stimulatory
effect.
PTS: 1
3. Stimulation of the beta 2 receptors causes
a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
ANS: C
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
PTS: 1
4. What immunoglobulin antibody sensitizes the mast cell?
a. Leukotrienes c. Histamine
, b. IgE d. Prostaglandins
ANS: B
The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the antigen causes the
degranulation of the mast cell.
PTS: 1
5. Which of the following is caused by histamine release from the mast cells?
I. Bronchodilation
II. Increased bronchial gland secretion
III. Increased amount of mucus present in the airways
a. I and II only c. III only
b. II and III only d. I, II, III
ANS: B
Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity, histamine
II) increases bronchial gland secretion, causing III) an increase in the amount of mucus present
in the airways. Histamine may also have an effect on vascular permeability similar to the effect of-
SRS-A.
PTS: 1
6. A sympathomimetic drug would cause
a. bronchodilation. c. Histamine release.
b. bronchoconstriction. d. Vagus nerve stimulation.
ANS: A
A sympathomimetic drug would cause bronchodilation. Sympathomimetic agents are the drugs most
commonly used to reverse bronchospasm.
PTS: 1
7. Stimulation of the sympathetic nervous system causes
a. vascular permeability. c. bronchodilation.
b. decreased blood pressure. d. bronchoconstriction.
ANS: C
Sympathetic nervous system stimulation causes bronchodilation.
PTS: 1
8. Which of the following would NOT cause a bronchospasm or bronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta 1 receptors d. Prostaglandins
ANS: B
Beta-1 receptors would not cause a bronchospasm or bronchoconstriction. Leukotrienes are one of
many chemical mediators released by the mast cells. Leukotrienes cause a direct, strong
bronchoconstriction. Histamine is also a potent bronchoconstrictor. Prostaglandins cause a strong
bronchospasm, especially in asthmatic patients.
PTS: 1
Rau's Respiratory Care Pharmacology 11th Edition by Douglas S. Gardenhire.
This complete test bank for Rau's Respiratory Care Pharmacology provides fully verified exam questions and answers
designed to help respiratory therapy students master key drug concepts, clinical applications, and pharmacologic
principles.
It includes chapter-specific questions, rationales, and updated practice sets covering respiratory drug classes,
therapeutic applications, mechanisms of action, side-effect profiles, and patient-care scenarios.
Perfect for RT students, nursing students, and health-science learners who want accurate, high-quality study material
that mirrors real course assessments.
Download instantly and start preparing with confidence.
Description
Test Bank for Rau’s Respiratory Care Pharmacology 11th Edition Gardenhire
, Table of Contents
ni andaUnit
akan I: menemui bahanand
Basic Concepts pembelajaran
Principles inyang disusun dengan teliti untuk membantu anda
Pharmacology
belajar dengan lebih mudah dan berkesan. Setiap dokumen direka secara teratur supaya maklumat
1. Introduction
penting senang to Respiratory
difahami Care
dan diingati. Pharmacology
Bahan ini sesuai untuk persediaan peperiksaan, ulang kaji,
2. Principles of Drug Action
dan pengukuhan pengetahuan. Kualiti dan ketepatan sentiasa menjadi keutamaan, memastikan
3. Administration
anda boleh belajar dengan of Aerosolized Agents
yakin. Pelajar menghargai ringkasan yang jelas dan penerangan
4. Calculating Drug Doses
praktikal yang menjimatkan masa serta mengurangkan tekanan. Matlamat saya adalah untuk
5. The
menjadikan Central and Peripheral
pengalaman Nervous
belajar anda lebih Systems
teratur dan produktif. Muat turun dengan keyakinan dan
gunakan sumber ini untuk meningkatkan prestasi akademik anda secara konsisten.
Unit II: Drugs Used to Treat the Respiratory System
Czech (±130 words)
6. Adrenergic (Sympathomimetic) Bronchodilators
Vítejte v7.mém
Anticholinergic
obchodě na (Parasympatholytic)
Stuvia! Najdete zdeBronchodilators
pečlivě připravené studijní materiály navržené tak,
8. Xanthines
aby bylo učení jednodušší a efektivnější. Každý dokument má přehlednou strukturu, která
usnadňuje9. Mucus-Controlling Drug informací.
pochopení důležitých Therapy Materiály jsou ideální pro přípravu na zkoušky,
10. Surfactant Agents
opakování i prohlubování znalostí. Důraz je kladen na kvalitu a spolehlivost, takže můžete studovat
11.Studenti
s jistotou. Corticosteriods
oceňujíinj Respiratory Care
12. Nonsteroidal Antiasthma Agents
13. Aerosolized Antiinfective Agents
14. Antimicrobial Agents
15. Cold and Cough Agents
16. Selected Agents of Pulmonary Value
17. Neonatal and Pediatric Aerosolized Drug Therapy
Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
19. Diuretic Agents
20. Drugs Affecting the Central Nervous System
21. Vasopressors, Inotropes, and Antiarrythmic Agents
22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
23. Sleep and Sleep Pharmacology
,Chapter 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th Edition
MULTIPLE CHOICE
1. Acetylcholine stimulates
a. the Vagus nerve.
b. the adrenergic receptors.
c. the sympathetic nervous system.
d. the cholinergic receptors.
ANS: D
Acetylcholine stimulates the cholinergic receptors.
PTS: 1
2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an increased
cardiac output?
a. Beta 1 receptor c. Alpha receptor
b. Beta 2 receptor d. Delta receptor
ANS: A
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias, and
an increased cardiac output. In administering drugs to the pulmonary system, stimulation of the beta-1
sites is not desired. However, most respiratory pharmacologic agents have some beta-1 stimulatory
effect.
PTS: 1
3. Stimulation of the beta 2 receptors causes
a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
ANS: C
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
PTS: 1
4. What immunoglobulin antibody sensitizes the mast cell?
a. Leukotrienes c. Histamine
, b. IgE d. Prostaglandins
ANS: B
The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the antigen causes the
degranulation of the mast cell.
PTS: 1
5. Which of the following is caused by histamine release from the mast cells?
I. Bronchodilation
II. Increased bronchial gland secretion
III. Increased amount of mucus present in the airways
a. I and II only c. III only
b. II and III only d. I, II, III
ANS: B
Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity, histamine
II) increases bronchial gland secretion, causing III) an increase in the amount of mucus present
in the airways. Histamine may also have an effect on vascular permeability similar to the effect of-
SRS-A.
PTS: 1
6. A sympathomimetic drug would cause
a. bronchodilation. c. Histamine release.
b. bronchoconstriction. d. Vagus nerve stimulation.
ANS: A
A sympathomimetic drug would cause bronchodilation. Sympathomimetic agents are the drugs most
commonly used to reverse bronchospasm.
PTS: 1
7. Stimulation of the sympathetic nervous system causes
a. vascular permeability. c. bronchodilation.
b. decreased blood pressure. d. bronchoconstriction.
ANS: C
Sympathetic nervous system stimulation causes bronchodilation.
PTS: 1
8. Which of the following would NOT cause a bronchospasm or bronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta 1 receptors d. Prostaglandins
ANS: B
Beta-1 receptors would not cause a bronchospasm or bronchoconstriction. Leukotrienes are one of
many chemical mediators released by the mast cells. Leukotrienes cause a direct, strong
bronchoconstriction. Histamine is also a potent bronchoconstrictor. Prostaglandins cause a strong
bronchospasm, especially in asthmatic patients.
PTS: 1
